BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30665678)

  • 1. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
    Dong Z; Wang Y
    Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00324 accelerates the proliferation and migration of osteosarcoma through regulating WDR66.
    Wu S; Gu Z; Wu Y; Wu W; Mao B; Zhao S
    J Cell Physiol; 2020 Jan; 235(1):339-348. PubMed ID: 31225659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression.
    Zhao D; Wang S; Chu X; Han D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1342-1348. PubMed ID: 30966832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA Bladder Cancer Associated Transcript 1 Promotes the Proliferation, Migration, and Invasion of Nonsmall Cell Lung Cancer Through Sponging miR-144.
    Ye JR; Liu L; Zheng F
    DNA Cell Biol; 2017 Oct; 36(10):845-852. PubMed ID: 28885863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway.
    Wang CH; Li YH; Tian HL; Bao XX; Wang ZM
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3002-3009. PubMed ID: 29863244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unlocking the Therapeutic Potential of LncRNA
    Liu FL; Zhang ZC; Zhou SL; Liu XL; Xu W
    Discov Med; 2024 Mar; 36(182):546-558. PubMed ID: 38531795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of lncRNA SNHG12 reversed IGF1R-induced osteosarcoma metastasis and proliferation by targeting miR-195-5p.
    Xu N; Xu J; Zuo Z; Liu Y; Yan F; Han C
    Gene; 2020 Feb; 726():144145. PubMed ID: 31743769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
    Chen S; Li W; Guo A
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
    He R; Wu JX; Zhang Y; Che H; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis.
    Zhou Y; Yin L; Li H; Liu LH; Xiao T
    Cancer Biol Ther; 2019; 20(8):1141-1148. PubMed ID: 30975024
    [No Abstract]   [Full Text] [Related]  

  • 11. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
    Wang Z; Tan M; Chen G; Li Z; Lu X
    IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation.
    Zhao W; Zhang D; Qin P; Zhang J; Cui X; Gao J; Wang J; Li J
    Int J Biol Macromol; 2019 May; 128():566-573. PubMed ID: 30703420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA SNHG1 negatively regulates miRNA‑101‑3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma.
    Deng R; Zhang J; Chen J
    Int J Mol Med; 2019 Mar; 43(3):1157-1166. PubMed ID: 30592267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis.
    Wang X; Hu K; Chao Y; Wang L
    Biomed Pharmacother; 2019 Jun; 114():108798. PubMed ID: 30909141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linc00460 promotes osteosarcoma progression via miR-1224-5p/FADS1 axis.
    Lian H; Xie P; Yin N; Zhang J; Zhang X; Li J; Zhang C
    Life Sci; 2019 Sep; 233():116757. PubMed ID: 31419446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM59 promotes osteosarcoma progression via activation of STAT3.
    Xu G; Ma Z; Yang F; Bai Y; Li J; Luo W; Zhong J
    Hum Cell; 2022 Jan; 35(1):250-259. PubMed ID: 34625908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
    Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
    Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.
    Qu Y; Zheng S; Kang M; Dong R; Zhou H; Zhao D; Zhao J
    Biomed Pharmacother; 2018 Feb; 98():899-906. PubMed ID: 29571260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SP1-induced upregulation of long non-coding RNA HCP5 promotes the development of osteosarcoma.
    Zhao W; Li L
    Pathol Res Pract; 2019 Mar; 215(3):439-445. PubMed ID: 30554864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.